Qun Liu Selected Research

Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial)

3/2007	Apolipoprotein B is associated with metabolic syndrome in Chinese families with familial combined hyperlipidemia, familial hypertriglyceridemia and familial hypercholesterolemia.
2/2007	Associations of apolipoprotein B with pulse pressure and glucose in Chinese families with familial combined hyperlipidemia.
3/2004	[An association of apolipoprotein B with pulse pressure in Chinese pedigrees with familial combined hyperlipidemia].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qun Liu Research Topics

Disease

43	Neoplasms (Cancer) 01/2022 - 05/2003
23	Infections 03/2021 - 11/2004
16	Breast Neoplasms (Breast Cancer) 03/2020 - 11/2009
14	Neoplasm Metastasis (Metastasis) 12/2021 - 09/2009
9	Burns 12/2015 - 06/2004
7	Non-alcoholic Fatty Liver Disease 01/2022 - 02/2018
6	Inflammation (Inflammations) 01/2022 - 03/2015
6	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 11/2008
6	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2012
6	Hypoxia (Hypoxemia) 01/2021 - 06/2009
6	Body Weight (Weight, Body) 08/2020 - 06/2012
6	Myocardial Ischemia (Ischemic Heart Diseases) 04/2020 - 06/2009
6	Glioma (Gliomas) 01/2020 - 05/2012
5	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 11/2012
5	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 01/2015
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 05/2007
4	Toxoplasmosis 06/2022 - 03/2012
4	Hypertension (High Blood Pressure) 01/2022 - 03/2009
4	Carcinogenesis 12/2021 - 01/2015
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 12/2018
4	Colonic Neoplasms (Colon Cancer) 01/2020 - 01/2015
4	Ischemia 01/2019 - 11/2012
4	Wounds and Injuries (Trauma) 08/2016 - 02/2006
3	Necrosis 10/2022 - 01/2015
3	Fibrosis (Cirrhosis) 07/2022 - 01/2020
3	Coronary Disease (Coronary Heart Disease) 01/2022 - 04/2009
3	Brain Injuries (Brain Injury) 01/2022 - 11/2012
3	Obesity 01/2022 - 11/2012
3	Hyperglycemia 01/2022 - 10/2018
3	Heart Failure 09/2021 - 12/2017
3	Lung Neoplasms (Lung Cancer) 06/2021 - 05/2020
3	Coccidiosis 03/2021 - 11/2004
3	Myocardial Infarction 01/2021 - 12/2012
3	Neuralgia (Stump Neuralgia) 01/2020 - 05/2003
3	Type 2 Diabetes Mellitus (MODY) 01/2017 - 01/2015
3	Carcinoma (Carcinomatosis) 05/2016 - 07/2004
3	Leukemia 02/2016 - 11/2013
3	Stroke (Strokes) 01/2016 - 04/2008
3	Myasthenia Gravis 01/2015 - 08/2012
3	Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial) 03/2007 - 03/2004
2	Parkinson Disease (Parkinson's Disease) 01/2022 - 04/2012
2	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2022 - 01/2019
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 12/2021
2	Brain Ischemia (Cerebral Ischemia) 01/2022 - 03/2015
2	Erectile Dysfunction 01/2022 - 01/2018
2	Acute Lung Injury 12/2021 - 01/2015
2	Pain (Aches) 11/2021 - 02/2021
2	Cardiac Arrhythmias (Arrythmia) 09/2021 - 07/2021
2	Stomach Neoplasms (Stomach Cancer) 01/2021 - 05/2016

Drug/Important Bio-Agent (IBA)

37	Proteins (Proteins, Gene)FDA Link 10/2022 - 02/2007
11	Biological ProductsIBA 12/2021 - 05/2011
9	Messenger RNA (mRNA)IBA 10/2022 - 11/2012
8	VaccinesIBA 06/2022 - 11/2004
7	Long Noncoding RNAIBA 01/2022 - 05/2019
7	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2007
7	AntigensIBA 03/2021 - 10/2008
6	Pharmaceutical PreparationsIBA 06/2021 - 05/2003
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 05/2003
5	LipidsIBA 01/2022 - 11/2012
5	Estrogen ReceptorsIBA 01/2018 - 11/2009
4	Small Interfering RNA (siRNA)IBA 10/2022 - 05/2012
4	MicroRNAs (MicroRNA)IBA 12/2018 - 01/2015
4	shogaolIBA 01/2015 - 01/2012
3	AluminumIBA 10/2022 - 01/2021
3	Neuroprotective AgentsIBA 01/2022 - 01/2014
3	EnzymesIBA 01/2022 - 01/2016
3	Glucagon (Glukagon)FDA Link 01/2022 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 12/2021 - 11/2009
3	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 09/2009
3	DNA (Deoxyribonucleic Acid)IBA 10/2018 - 06/2012
3	AntibodiesIBA 10/2018 - 10/2012
3	ParaffinIBA 01/2018 - 09/2009
3	Succinic Acid (Succinate)IBA 01/2018 - 01/2017
3	GinsenosidesIBA 01/2018 - 02/2015
3	Indicators and Reagents (Reagents)IBA 12/2017 - 11/2009
3	CaspasesIBA 01/2017 - 01/2012
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2015 - 11/2012
3	HDL CholesterolIBA 02/2014 - 05/2007
3	Caspase 3 (Caspase-3)IBA 11/2013 - 01/2012
3	ApolipoproteinsIBA 03/2007 - 03/2004
2	Phosphotransferases (Kinase)IBA 10/2022 - 06/2011
2	Interleukin-1 (Interleukin 1)IBA 07/2022 - 06/2018
2	Transforming Growth Factors (Transforming Growth Factor)IBA 07/2022 - 03/2015
2	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 09/2019
2	AntioxidantsIBA 01/2022 - 01/2015
2	CarcinogensIBA 12/2021 - 05/2017
2	CarrageenanIBA 11/2021 - 06/2018
2	AconitineIBA 09/2021 - 07/2021
2	Propranolol (Inderal)FDA LinkGeneric 09/2021 - 07/2021
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2021 - 01/2020
2	CollagenIBA 01/2021 - 01/2020

Therapy/Procedure

16	Therapeutics 01/2022 - 09/2009
9	Electroacupuncture 07/2022 - 09/2018
6	Drug Therapy (Chemotherapy) 01/2021 - 05/2003
4	Immunotherapy 01/2022 - 08/2010
4	Transplantation 01/2022 - 04/2012
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 05/2012
4	Secondary Prevention 08/2011 - 06/2008
3	Oral Administration 01/2017 - 05/2003
3	Microspheres (Microsphere) 06/2015 - 10/2009